Ruilan Wang
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia (NCT02707497) | Ruilan Wang | 2019-04-01 |
Track Ruilan Wang automatically
Every clearance here is in the API, with alerts when new ones post.